Xuebijing injection and its bioactive components alleviate nephrotic syndrome by inhibiting podocyte inflammatory injury
Article in European Journal of Pharmaceutical Sciences (April 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutical Sciences (April 2024)
Article in Reproductive Sciences (March 2024)
Article in Tissue and Cell (September 2023)